Lower Rates of Staphylococcus aureus Bloodstream Infection in Patients on Hemodialysis Receiving Trimethoprim-Sulfamethoxazole Melioidosis Prophylaxis

被引:4
作者
Bryce, Aliya [1 ,2 ]
Davison, Sara [1 ]
Currie, Bart J. [1 ,3 ]
Birrell, Johanna M. [4 ]
Baird, Robert W. [1 ]
Abeyaratne, Asanga [3 ,5 ,6 ,7 ]
Majoni, Sandawana William [3 ,5 ,6 ,7 ]
Brewster-O'Brien, Teana [5 ]
Tong, Steven Y. C. [8 ,9 ]
机构
[1] Royal Darwin Hosp, Dept Infect Dis, Darwin, NT, Australia
[2] Royal Melbourne Hosp, Dept Gen Med, 300 Grattan St, Melbourne, Vic 3052, Australia
[3] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia
[4] NT Hlth, Northern Terr Ctr Dis Control, Darwin, NT, Australia
[5] Royal Darwin Hosp, Dept Nephrol, Darwin, NT, Australia
[6] Flinders Univ S Australia, Darwin, NT, Australia
[7] Royal Darwin Hosp Campus, Northern Terr Med Program, Darwin, NT, Australia
[8] Royal Melbourne Hosp, Peter Doherty Inst Infect & Immun, Victorian Infect Dis Serv, Melbourne, Vic, Australia
[9] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Infect Dis, Melbourne, Vic, Australia
关键词
antibiotic prophylaxis; bloodstream infection; hemodialysis; Staphylococcus aureus; trimethoprim-sulfamethoxazole; RISK; BACTEREMIA;
D O I
10.1093/ofid/ofae431
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hemodialysis is a risk factor for Staphylococcus aureus bloodstream infection (SAB). In this single-center study, SAB rates were 56% lower during the monsoonal wet season when patients on hemodialysis receive supervised melioidosis prophylaxis with trimethoprim-sulfamethoxazole. This intervention may reduce SAB rates in high-risk patients; however, further targeted studies are required. Graphical abstract https://tidbitapp.io/institutional-portal/open-forum-infectious-diseases/tidbits/lower-rates-of-staphylococcus-aureus-bloodstream-infection-in-patients-on-hemodialysis-receiving-trimethoprim-sulfamethoxazole-melioidosis-prophylaxis/update In the Northern Territory of Australia, patients on hemodialysis receive seasonal post-dialysis Trimethoprim-Sulfamethoxazole as melioidosis prophylaxis. This single-center study explored the effect of this intervention on rates of Staphylococcus Aureus bloodstream infections in this high risk group.
引用
收藏
页数:4
相关论文
共 50 条
[31]   Bloodstream Infection and Endocarditis Caused by Staphylococcus aureus in Patients with Cancer: A Multicenter Cohort Study [J].
Grillo, Sara ;
Cuervo, Guillermo ;
Laporte-Amargos, Julia ;
Tuells, Manel ;
Grau, Immaculada ;
Berbel, Damaris ;
Gudiol, Carlota ;
Pujol, Miquel ;
Carratala, Jordi .
INFECTIOUS DISEASES AND THERAPY, 2022, 11 (01) :323-334
[32]   Outcomes of Staphylococcus aureus Infection in Hemodialysis-Dependent Patients [J].
Li, Yanhong ;
Friedman, Joelle Y. ;
O'Neal, Betsy F. ;
Hohenboken, Matthew J. ;
Griffiths, Robert I. ;
Stryjewski, Martin E. ;
Middleton, John P. ;
Schulman, Kevin A. ;
Inrig, Jula K. ;
Fowler, Vance G., Jr. ;
Reed, Shelby D. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (02) :428-434
[33]   Staphylococcus aureus nasal carriage and bloodstream infection among conventional hemodialysis patients in Thailand: a prospective multicenter cohort study [J].
Tanyanop Techasupaboon ;
Vasin Vasikasin ;
Narittaya Varothai ;
Navee Raknaisil ;
Worapong Nasomsong .
BMC Research Notes, 15
[34]   Infection Control and Bloodstream Infection Prevention: The Perspective Of Patients Receiving Hemodialysis [J].
See, Isaac ;
Shugart, Alicia ;
Lamb, Carrie ;
Kallen, Alexander J. ;
Patel, Priti R. ;
Sinkowitz-Cochran, Ronda L. .
NEPHROLOGY NURSING JOURNAL, 2014, 41 (01) :37-+
[35]   TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS AGAINST URINARY-TRACT INFECTION IN THE CHRONIC SPINAL-CORD INJURY PATIENT [J].
SANDOCK, DS ;
GOTHE, BG ;
BODNER, DR .
PARAPLEGIA, 1995, 33 (03) :156-160
[36]   Vertebral osteomyelitis in patients with Staphylococcus aureus bloodstream infection: Evaluation of risk factors for treatment failure [J].
Jung, N. ;
Ernst, A. ;
Joost, I ;
Yagdiran, A. ;
Peyerl-Hoffmann, G. ;
Grau, S. ;
Breuninger, M. ;
Hellmich, M. ;
Kubosch, D. C. ;
Klingler, J. H. ;
Seifert, H. ;
Kern, W., V ;
Kaasch, A. J. ;
Rieg, S. .
JOURNAL OF INFECTION, 2021, 83 (03) :314-320
[37]   Twice Weekly Pneumocystis jiroveci Pneumonia Prophylaxis With Trimethoprim-Sulfamethoxazole in Pediatric Patients With Acute Lymphoblastic Leukemia [J].
Agrawal, Anurag K. ;
Chang, Patrick P. ;
Feusner, James .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2011, 33 (01) :E1-E4
[38]   Clinical Characteristics and Epidemiological Analysis of Pneumocystis Jirovecii Pneumonia Infection in Kidney Transplant Patients with Trimethoprim-Sulfamethoxazole Dose Reduction Prophylaxis Strategy [J].
Shan, Wenya ;
Wang, Liangping ;
Qin, Jiayi ;
Peng, Wenhan ;
Ma, Kuifen .
INFECTION AND DRUG RESISTANCE, 2024, 17 :2299-2306
[39]   Trimethoprim-sulfamethoxazole prevents interstitial pneumonitis in B-cell lymphoma patients receiving chemotherapy: a propensity score matching analysis [J].
Liu, Chunxiao ;
Zhang, Xuewu ;
Zhu, Yanan ;
Wei, Juying ;
Ye, Xingnong ;
Yang, Chunmei ;
Tong, Hongyan ;
Mai, Wenyuan ;
Yang, Min ;
Qian, Jiejing ;
Mao, Liping ;
Meng, Haitao ;
Jin, Jie ;
Yu, Wenjuan .
ANNALS OF HEMATOLOGY, 2023, 102 (09) :2387-2395
[40]   Effect of trimethoprim-sulfamethoxazole prophylaxis on antimicrobial resistance of fecal Escherichia coli in HIV-infected patients in Tanzania [J].
Morpeth, Susan C. ;
Thielman, Nathan M. ;
Ramadhani, Habib O. ;
Hamilton, John D. ;
Ostermann, Jan ;
Kisenge, Peter R. ;
Shao, Humphrey J. ;
Reller, L. Barth ;
Itemba, Dafrosa K. ;
Sam, Noel E. ;
Bartlett, John A. ;
Shao, John F. ;
Crump, John A. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 47 (05) :585-591